Back Bay Sponsors DKBIO2019 – Danish Science & the City: New York City

Back Bay is proud to join Novo Holdings and Lundbeckfonden in Viking sponsorship of DKBIO19: Danish Science & the City.

As leaders in Nordic and North-American life science development, Back Bay facilitates collaboration between these thriving ecosystems. Through ongoing alliances with groups like the Royal Danish Consulate, we’re delighted to help drive international investment and collaboration.

With an emphasis on clinical trials and personalized medicine, DKBIO2019 will open with comments by Ambassador, Consul General of Denmark in New York, Anne Dorte Riggelsen. The conference will include presentations by Danish companies, Novartis head of public policy, Wired Magazine, among others.

Join Back Bay’s strategy and consulting teams at DKBIO19: Danish Science & the City, New York, April 10 – April 11, 2019.

Learn more about DKBio2019 and register for the event here.

A Gutsy Combination: The Microbiome and Immuno-oncology

A Gutsy Combination: The Microbiome and Immuno-oncology

As science explores the effects of the microbiome on the immune system and its role in treating cancer, drug developers are investing substantially to capitalize on findings connecting the microbiome, immunology, and oncology.

For our latest white paper, Back Bay Life Science Advisors analyzed the activity of drug developers looking to harness microbial pathways to improve cancer treatment, the current drug pipeline, active clinical trials, and evolving regulatory and IP issues for the development of these technologies.

Download the full white paper here